Intuitive Surgical Inc

AI Summary

Intuitive Surgical develops surgical robots used by physicians to perform minimally invasive procedures — think laparoscopic surgery where a surgeon controls robotic arms through a console instead of making large incisions. Their flagship da Vinci system dominates the global surgical robotics market, and they also sell the Ion system for lung biopsies. Revenue comes from selling the multi-million-dollar systems, plus ongoing sales of single-use instruments, accessories, and service contracts.

Intuitive Surgical manufactures the da Vinci Surgical System, a robot-assisted platform enabling minimally invasive surgeries, and the Ion endoluminal system for lung biopsies [Yahoo Finance]. The company reported $10.1B in revenue (+20.5% YoY) with exceptional profitability (28.4% net margin) and a pristine balance sheet [Yahoo Finance]. Recent insider selling and a 53.8x P/E ratio warrant attention, though institutional holders remain largely stable [SEC Form 4] [EODHD].

Intuitive Surgical is financially excellent: growing fast, highly profitable, and completely debt-free.

Recent News

• Intuit to lay off over 3,000 employees to refocus on AI

  Yahoo Finance· 2026-05-20

• Is It Time To Reassess Intuit (INTU) After This Year’s Sharp Share Price Slide

  Simply Wall St· 2026-05-20

• TD Cowen Expects Strong Q3 Performance from Intuit (INTU)

  Yahoo Finance· 2026-05-20

• Intuit layoffs: 3,000 jobs cut in AI restructuring 2026

  Yahoo Finance· 2026-05-20

• Intuit Expands QuickBooks With AI: Will It Accelerate Growth?

  Yahoo Finance· 2026-05-19

• Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

  Zacks· 2026-05-19